Generics Global Industry Almanac 2020-2029

Global Generics industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume , and forecast to 2029). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights

A generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and branded generics are included in our market scope. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included. Market value is evaluated at ex-factory prices. Market volume refers to the proportion of the total ethical pharmaceutical market in a country or region that is made up of generic drugs. Thus, it is a measure of the market share held by generics, rather than a direct measure of the total market volume. Regional volumes are calculated as averages of countries that comprise the region where volume data exists.

All market data and forecasts are based on nominal prices, and all currency conversions used in the creation of this report have been calculated using yearly average exchange rates. The USD values may show a declining trend for a few countries, such as Argentina, Turkey, Nigeria, Egypt, and Russia. This is primarily because of the impact of exchange rates considered.

The global generics market recorded revenues of $426.7 billion in 2024, representing a compound annual growth rate (CAGR) of 7.7% between 2019 and 2024.

Market consumption volume increased with a CAGR of 1.3% between 2019 and 2024, reaching a total of 72.9% of total pharma volume in 2024.

In 2024, the revenue of the global generics market experienced an annual growth of 8.1%. The market's growth is driven by the rising prevalence of chronic diseases such as diabetes, hypertension, and cardiovascular conditions, increasing the demand for affordable, long-term medications.

Scope

Save time carrying out entry-level research by identifying the size, growth, and leading players in the global generics market
Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the global generics market
Leading company profiles reveal details of key generics market players' global operations and financial performance
Add weight to presentations and pitches by understanding the future growth prospects of the global generics market with five year forecasts by both value and volume

Reasons to Buy

What was the size of the global generics market by value in 2024?
What will be the size of the global generics market in 2029?
What factors are affecting the strength of competition in the global generics market?
How has the market performed over the last five years?
How large is the global generics market in relation to its regional counterparts?

Product Code: MLIG250030-01

1 EXECUTIVE SUMMARY

1.1. Market value
1.2. Market value forecast
1.3. Market volume
1.4. Market volume forecast
1.5. Geography segmentation
1.6. Competitive landscape

2 Introduction

2.1. What is this report about?
2.2. Who is the target reader?
2.3. How to use this report
2.4. Definitions

3 Global Generics

3.1. Market Overview
3.2. Market Data
3.3. Market Segmentation
3.4. Market outlook
3.5. Five forces analysis

4 Macroeconomic Indicators

4.1. Country data

5 Generics in Asia-Pacific

5.1. Market Overview
5.2. Market Data
5.3. Market Segmentation
5.4. Market outlook
5.5. Five forces analysis

6 Generics in Europe

6.1. Market Overview
6.2. Market Data
6.3. Market Segmentation
6.4. Market outlook
6.5. Five forces analysis

7 Macroeconomic Indicators

7.1. Country data

8 Generics in France

8.1. Market Overview
8.2. Market Data
8.3. Market Segmentation
8.4. Market outlook
8.5. Five forces analysis

9 Macroeconomic Indicators

9.1. Country data

10 Generics in Germany

10.1. Market Overview
10.2. Market Data
10.3. Market Segmentation
10.4. Market outlook
10.5. Five forces analysis

11 Macroeconomic Indicators

11.1. Country data

12 Generics in Australia

12.1. Market Overview
12.2. Market Data
12.3. Market Segmentation
12.4. Market outlook
12.5. Five forces analysis

13 Macroeconomic Indicators

13.1. Country data

14 Generics in Brazil

14.1. Market Overview
14.2. Market Data
14.3. Market Segmentation
14.4. Market outlook
14.5. Five forces analysis

15 Macroeconomic Indicators

15.1. Country data

16 Generics in Canada

16.1. Market Overview
16.2. Market Data
16.3. Market Segmentation
16.4. Market outlook
16.5. Five forces analysis

17 Macroeconomic Indicators

17.1. Country data

18 Generics in China

18.1. Market Overview
18.2. Market Data
18.3. Market Segmentation
18.4. Market outlook
18.5. Five forces analysis

19 Macroeconomic Indicators

19.1. Country data

20 Generics in India

20.1. Market Overview
20.2. Market Data
20.3. Market Segmentation
20.4. Market outlook
20.5. Five forces analysis

21 Macroeconomic Indicators

21.1. Country data

22 Generics in Indonesia

22.1. Market Overview
22.2. Market Data
22.3. Market Segmentation
22.4. Market outlook
22.5. Five forces analysis

23 Macroeconomic Indicators

23.1. Country data

24 Generics in Italy

24.1. Market Overview
24.2. Market Data
24.3. Market Segmentation
24.4. Market outlook
24.5. Five forces analysis

25 Macroeconomic Indicators

25.1. Country data

26 Generics in Japan

26.1. Market Overview
26.2. Market Data
26.3. Market Segmentation
26.4. Market outlook
26.5. Five forces analysis

27 Macroeconomic Indicators

27.1. Country data

28 Generics in Mexico

28.1. Market Overview
28.2. Market Data
28.3. Market Segmentation
28.4. Market outlook
28.5. Five forces analysis

29 Macroeconomic Indicators

29.1. Country data

30 Generics in The Netherlands

30.1. Market Overview
30.2. Market Data
30.3. Market Segmentation
30.4. Market outlook
30.5. Five forces analysis

31 Macroeconomic Indicators

31.1. Country data

32 Generics in North America

32.1. Market Overview
32.2. Market Data
32.3. Market Segmentation
32.4. Market outlook
32.5. Five forces analysis

33 Generics in Russia

33.1. Market Overview
33.2. Market Data
33.3. Market Segmentation
33.4. Market outlook
33.5. Five forces analysis

34 Macroeconomic Indicators

34.1. Country data

35 Generics in Scandinavia

35.1. Market Overview
35.2. Market Data
35.3. Market Segmentation
35.4. Market outlook
35.5. Five forces analysis

36 Generics in Singapore

36.1. Market Overview
36.2. Market Data
36.3. Market Segmentation
36.4. Market outlook
36.5. Five forces analysis

37 Macroeconomic Indicators

37.1. Country data

38 Generics in South Africa

38.1. Market Overview
38.2. Market Data
38.3. Market Segmentation
38.4. Market outlook
38.5. Five forces analysis

39 Macroeconomic Indicators

39.1. Country data

40 Generics in South Korea

40.1. Market Overview
40.2. Market Data
40.3. Market Segmentation
40.4. Market outlook
40.5. Five forces analysis

41 Macroeconomic Indicators

41.1. Country data

42 Generics in Spain

42.1. Market Overview
42.2. Market Data
42.3. Market Segmentation
42.4. Market outlook
42.5. Five forces analysis

43 Macroeconomic Indicators

43.1. Country data

44 Generics in Turkey

44.1. Market Overview
44.2. Market Data
44.3. Market Segmentation
44.4. Market outlook
44.5. Five forces analysis

45 Macroeconomic Indicators

45.1. Country data

46 Generics in The United Kingdom

46.1. Market Overview
46.2. Market Data
46.3. Market Segmentation
46.4. Market outlook
46.5. Five forces analysis

47 Macroeconomic Indicators

47.1. Country data

48 Generics in The United States

48.1. Market Overview
48.2. Market Data
48.3. Market Segmentation
48.4. Market outlook
48.5. Five forces analysis

49 Macroeconomic Indicators

49.1. Country data

50 Company Profiles

50.1. Sun Pharmaceutical Industries Ltd
50.2. Viatris Inc
50.3. Novartis AG
50.4. Teva Pharmaceutical Industries Ltd
50.5. Sandoz Group AG
50.6. Hikma Pharmaceuticals Plc
50.7. Sanofi
50.8. Les Laboratoires Servier SAS
50.9. Stada Arzneimittel AG
50.10. Bayer AG
50.11. Lupin Ltd
50.12. Aspen Pharmacare Holdings Ltd
50.13. EMS SA
50.14. Eurofarma Laboratorios SA
50.15. Ache Laboratorios Farmaceuticos SA
50.16. Sino Biopharmaceutical Ltd
50.17. Hansoh Pharmaceutical Group Co Ltd
50.18. CSPC Pharmaceutical Group Ltd
50.19. Dr. Reddy's Laboratories Ltd
50.20. Cipla Ltd
50.21. Aurobindo Pharma Ltd
50.22. PT Indofarma Tbk
50.23. PT Sanbe Farma
50.24. PT Kalbe Farma Tbk
50.25. PT Soho Global Health Tbk
50.26. Friulchem SpA
50.27. DOC Generici SRL
50.28. Recordati SpA
50.29. Daiichi Sankyo Co Ltd
50.30. Sawai Group Holdings Co Ltd
50.31. Toho Holdings Co Ltd
50.32. Towa Pharmaceutical Co Ltd
50.33. Laboratorios Silanes SA de CV
50.34. Pfizer Inc
50.35. Bluefish Pharmaceuticals AB
50.36. AstraZeneca Plc
50.37. Navamedic ASA
50.38. Beacons Pharmaceuticals Pte Ltd
50.39. Abbott Laboratories SA
50.40. Adcock Ingram Holdings Ltd
50.41. Dongkook Pharmaceutical Co Ltd
50.42. JW Holdings Corp
50.43. Hanmi Pharmaceuticals Co Ltd
50.44. Dong Wha Pharma Co Ltd
50.45. Esteve Pharmaceuticals SA
50.46. Abdi Ibrahim Ilac Sanayi ve Ticaret AS
50.47. Deva Holding AS
50.48. Apotex Inc
50.49. Pharmstandard
50.50. Biocad
50.51. R-Pharm

51 Appendix

51.1. Methodology
51.2. About MarketLine

Product Code: MLIG250030-01

List of Tables

Table 1: Global generics market value: $ million, 2019-24
Table 2: Global generics market volume: % of total pharma volume, 2019-24
Table 3: Global generics market geography segmentation: $ million, 2024
Table 4: Global generics market value forecast: $ million, 2024-29
Table 5: Global generics market volume forecast: % of total pharma volume, 2024-29
Table 6: Global Size of Population (Million), 2020-24
Table 7: Global Real GDP (Constant 2010 Prices, $ Billion), 2020-24
Table 8: Global GDP (Current Prices, $ Billion), 2020-24
Table 9: Global Inflation, 2020-24
Table 10: Global Consumer Price Index (Absolute), 2020-24
Table 11: Global Exchange Rate, 2019-24
Table 12: Asia-Pacific generics market value: $ million, 2019-24
Table 13: Asia-Pacific generics market volume: % of total pharma volume, 2019-24
Table 14: Asia-Pacific generics market geography segmentation: $ million, 2024
Table 15: Asia-Pacific generics market value forecast: $ million, 2024-29
Table 16: Asia-Pacific generics market volume forecast: % of total pharma volume, 2024-29
Table 17: Europe generics market value: $ million, 2019-24
Table 18: Europe generics market volume: % of total pharma volume, 2019-24
Table 19: Europe generics market geography segmentation: $ million, 2024
Table 20: Europe generics market value forecast: $ million, 2024-29
Table 21: Europe generics market volume forecast: % of total pharma volume, 2024-29
Table 22: Europe Size of Population (Million), 2020-24
Table 23: Europe Real GDP (Constant 2010 Prices, $ Billion), 2020-24
Table 24: Europe GDP (Current Prices, $ Billion), 2020-24
Table 25: Europe Inflation, 2020-24
Table 26: Europe Consumer Price Index (Absolute), 2020-24
Table 27: Europe Exchange Rate, 2019-24
Table 28: France generics market value: $ million, 2019-24
Table 29: France generics market volume: % of total pharma volume, 2019-24
Table 30: France generics market geography segmentation: $ million, 2024
Table 31: France generics market value forecast: $ million, 2024-29
Table 32: France generics market volume forecast: % of total pharma volume, 2024-29
Table 33: France Size of Population (Million), 2020-24
Table 34: France Real GDP (Constant 2010 Prices, $ Billion), 2020-24
Table 35: France GDP (Current Prices, $ Billion), 2020-24
Table 36: France Inflation, 2020-24
Table 37: France Consumer Price Index (Absolute), 2020-24
Table 38: France Exchange Rate, 2019-24
Table 39: Germany generics market value: $ million, 2019-24
Table 40: Germany generics market volume: % of total pharma volume, 2019-24
Table 41: Germany generics market geography segmentation: $ million, 2024
Table 42: Germany generics market value forecast: $ million, 2024-29
Table 43: Germany generics market volume forecast: % of total pharma volume, 2024-29
Table 44: Germany Size of Population (Million), 2020-24
Table 45: Germany Real GDP (Constant 2010 Prices, $ Billion), 2020-24
Table 46: Germany GDP (Current Prices, $ Billion), 2020-24
Table 47: Germany Inflation, 2020-24
Table 48: Germany Consumer Price Index (Absolute), 2020-24
Table 49: Germany Exchange Rate, 2019-24
Table 50: Australia generics market value: $ million, 2019-24
Table 51: Australia generics market volume: % of total pharma volume, 2019-24
Table 52: Australia generics market geography segmentation: $ million, 2024
Table 53: Australia generics market value forecast: $ million, 2024-29
Table 54: Australia generics market volume forecast: % of total pharma volume, 2024-29
Table 55: Australia Size of Population (Million), 2020-24
Table 56: Australia Real GDP (Constant 2010 Prices, $ Billion), 2020-24
Table 57: Australia GDP (Current Prices, $ Billion), 2020-24
Table 58: Australia Inflation, 2020-24
Table 59: Australia Consumer Price Index (Absolute), 2020-24
Table 60: Australia Exchange Rate, 2019-24
Table 61: Brazil generics market value: $ million, 2019-24
Table 62: Brazil generics market volume: % of total pharma volume, 2019-24
Table 63: Brazil generics market geography segmentation: $ million, 2024
Table 64: Brazil generics market value forecast: $ million, 2024-29
Table 65: Brazil generics market volume forecast: % of total pharma volume, 2024-29
Table 66: Brazil Size of Population (Million), 2020-24
Table 67: Brazil Real GDP (Constant 2010 Prices, $ Billion), 2020-24
Table 68: Brazil GDP (Current Prices, $ Billion), 2020-24
Table 69: Brazil Inflation, 2020-24
Table 70: Brazil Consumer Price Index (Absolute), 2020-24
Table 71: Brazil Exchange Rate, 2019-24
Table 72: Canada generics market value: $ million, 2019-24
Table 73: Canada generics market volume: % of total pharma volume, 2019-24
Table 74: Canada generics market geography segmentation: $ million, 2024
Table 75: Canada generics market value forecast: $ million, 2024-29
Table 76: Canada generics market volume forecast: % of total pharma volume, 2024-29
Table 77: Canada Size of Population (Million), 2020-24
Table 78: Canada Real GDP (Constant 2010 Prices, $ Billion), 2020-24
Table 79: Canada GDP (Current Prices, $ Billion), 2020-24
Table 80: Canada Inflation, 2020-24
Table 81: Canada Consumer Price Index (Absolute), 2020-24
Table 82: Canada Exchange Rate, 2019-24
Table 83: China generics market value: $ million, 2019-24
Table 84: China generics market volume: % of total pharma volume, 2019-24
Table 85: China generics market geography segmentation: $ million, 2024
Table 86: China generics market value forecast: $ million, 2024-29
Table 87: China generics market volume forecast: % of total pharma volume, 2024-29
Table 88: China Size of Population (Million), 2020-24
Table 89: China Real GDP (Constant 2010 Prices, $ Billion), 2020-24
Table 90: China GDP (Current Prices, $ Billion), 2020-24
Table 91: China Inflation, 2020-24
Table 92: China Consumer Price Index (Absolute), 2020-24
Table 93: China Exchange Rate, 2019-24
Table 94: India generics market value: $ million, 2019-24
Table 95: India generics market volume: % of total pharma volume, 2019-24
Table 96: India generics market geography segmentation: $ million, 2024
Table 97: India generics market value forecast: $ million, 2024-29
Table 98: India generics market volume forecast: % of total pharma volume, 2024-29
Table 99: India Size of Population (Million), 2020-24
Table 100: India Real GDP (Constant 2010 Prices, $ Billion), 2020-24
Table 101: India GDP (Current Prices, $ Billion), 2020-24
Table 102: India Inflation, 2020-24
Table 103: India Consumer Price Index (Absolute), 2020-24
Table 104: India Exchange Rate, 2019-24

List of Figures

Figure 1: Global generics market value: $ million, 2019-24
Figure 2: Global generics market volume: % of total pharma volume, 2019-24
Figure 3: Global generics market geography segmentation: % share, by value, 2024
Figure 4: Global generics market value forecast: $ million, 2024-29
Figure 5: Global generics market volume forecast: % of total pharma volume, 2024-29
Figure 6: Forces driving competition in the global generics market, 2024
Figure 7: Drivers of buyer power in the global generics market, 2024
Figure 8: Drivers of supplier power in the global generics market, 2024
Figure 9: Factors influencing the likelihood of new entrants in the global generics market, 2024
Figure 10: Factors influencing the threat of substitutes in the global generics market, 2024
Figure 11: Drivers of degree of rivalry in the global generics market, 2024
Figure 12: Asia-Pacific generics market value: $ million, 2019-24
Figure 13: Asia-Pacific generics market volume: % of total pharma volume, 2019-24
Figure 14: Asia-Pacific generics market geography segmentation: % share, by value, 2024
Figure 15: Asia-Pacific generics market value forecast: $ million, 2024-29
Figure 16: Asia-Pacific generics market volume forecast: % of total pharma volume, 2024-29
Figure 17: Forces driving competition in the generics market in Asia-Pacific, 2024
Figure 18: Drivers of buyer power in the generics market in Asia-Pacific, 2024
Figure 19: Drivers of supplier power in the generics market in Asia-Pacific, 2024
Figure 20: Factors influencing the likelihood of new entrants in the generics market in Asia-Pacific, 2024
Figure 21: Factors influencing the threat of substitutes in the generics market in Asia-Pacific, 2024
Figure 22: Drivers of degree of rivalry in the generics market in Asia-Pacific, 2024
Figure 23: Europe generics market value: $ million, 2019-24
Figure 24: Europe generics market volume: % of total pharma volume, 2019-24
Figure 25: Europe generics market geography segmentation: % share, by value, 2024
Figure 26: Europe generics market value forecast: $ million, 2024-29
Figure 27: Europe generics market volume forecast: % of total pharma volume, 2024-29
Figure 28: Forces driving competition in the generics market in Europe, 2024
Figure 29: Drivers of buyer power in the generics market in Europe, 2024
Figure 30: Drivers of supplier power in the generics market in Europe, 2024
Figure 31: Factors influencing the likelihood of new entrants in the generics market in Europe, 2024
Figure 32: Factors influencing the threat of substitutes in the generics market in Europe, 2024
Figure 33: Drivers of degree of rivalry in the generics market in Europe, 2024
Figure 34: France generics market value: $ million, 2019-24
Figure 35: France generics market volume: % of total pharma volume, 2019-24
Figure 36: France generics market geography segmentation: % share, by value, 2024
Figure 37: France generics market value forecast: $ million, 2024-29
Figure 38: France generics market volume forecast: % of total pharma volume, 2024-29
Figure 39: Forces driving competition in the generics market in France, 2024
Figure 40: Drivers of buyer power in the generics market in France, 2024
Figure 41: Drivers of supplier power in the generics market in France, 2024
Figure 42: Factors influencing the likelihood of new entrants in the generics market in France, 2024
Figure 43: Factors influencing the threat of substitutes in the generics market in France, 2024
Figure 44: Drivers of degree of rivalry in the generics market in France, 2024
Figure 45: Germany generics market value: $ million, 2019-24
Figure 46: Germany generics market volume: % of total pharma volume, 2019-24
Figure 47: Germany generics market geography segmentation: % share, by value, 2024
Figure 48: Germany generics market value forecast: $ million, 2024-29
Figure 49: Germany generics market volume forecast: % of total pharma volume, 2024-29
Figure 50: Forces driving competition in the generics market in Germany, 2024
Figure 51: Drivers of buyer power in the generics market in Germany, 2024
Figure 52: Drivers of supplier power in the generics market in Germany, 2024
Figure 53: Factors influencing the likelihood of new entrants in the generics market in Germany, 2024
Figure 54: Factors influencing the threat of substitutes in the generics market in Germany, 2024
Figure 55: Drivers of degree of rivalry in the generics market in Germany, 2024
Figure 56: Australia generics market value: $ million, 2019-24
Figure 57: Australia generics market volume: % of total pharma volume, 2019-24
Figure 58: Australia generics market geography segmentation: % share, by value, 2024
Figure 59: Australia generics market value forecast: $ million, 2024-29
Figure 60: Australia generics market volume forecast: % of total pharma volume, 2024-29
Figure 61: Forces driving competition in the generics market in Australia, 2024
Figure 62: Drivers of buyer power in the generics market in Australia, 2024
Figure 63: Drivers of supplier power in the generics market in Australia, 2024
Figure 64: Factors influencing the likelihood of new entrants in the generics market in Australia, 2024
Figure 65: Factors influencing the threat of substitutes in the generics market in Australia, 2024
Figure 66: Drivers of degree of rivalry in the generics market in Australia, 2024
Figure 67: Brazil generics market value: $ million, 2019-24
Figure 68: Brazil generics market volume: % of total pharma volume, 2019-24
Figure 69: Brazil generics market geography segmentation: % share, by value, 2024
Figure 70: Brazil generics market value forecast: $ million, 2024-29
Figure 71: Brazil generics market volume forecast: % of total pharma volume, 2024-29
Figure 72: Forces driving competition in the generics market in Brazil, 2024
Figure 73: Drivers of buyer power in the generics market in Brazil, 2024
Figure 74: Drivers of supplier power in the generics market in Brazil, 2024
Figure 75: Factors influencing the likelihood of new entrants in the generics market in Brazil, 2024
Figure 76: Factors influencing the threat of substitutes in the generics market in Brazil, 2024
Figure 77: Drivers of degree of rivalry in the generics market in Brazil, 2024
Figure 78: Canada generics market value: $ million, 2019-24
Figure 79: Canada generics market volume: % of total pharma volume, 2019-24
Figure 80: Canada generics market geography segmentation: % share, by value, 2024
Figure 81: Canada generics market value forecast: $ million, 2024-29
Figure 82: Canada generics market volume forecast: % of total pharma volume, 2024-29
Figure 83: Forces driving competition in the generics market in Canada, 2024
Figure 84: Drivers of buyer power in the generics market in Canada, 2024
Figure 85: Drivers of supplier power in the generics market in Canada, 2024
Figure 86: Factors influencing the likelihood of new entrants in the generics market in Canada, 2024
Figure 87: Factors influencing the threat of substitutes in the generics market in Canada, 2024
Figure 88: Drivers of degree of rivalry in the generics market in Canada, 2024
Figure 89: China generics market value: $ million, 2019-24
Figure 90: China generics market volume: % of total pharma volume, 2019-24
Figure 91: China generics market geography segmentation: % share, by value, 2024
Figure 92: China generics market value forecast: $ million, 2024-29
Figure 93: China generics market volume forecast: % of total pharma volume, 2024-29
Figure 94: Forces driving competition in the generics market in China, 2024
Figure 95: Drivers of buyer power in the generics market in China, 2024
Figure 96: Drivers of supplier power in the generics market in China, 2024
Figure 97: Factors influencing the likelihood of new entrants in the generics market in China, 2024
Figure 98: Factors influencing the threat of substitutes in the generics market in China, 2024
Figure 99: Drivers of degree of rivalry in the generics market in China, 2024
Figure 100: India generics market value: $ million, 2019-24
Figure 101: India generics market volume: % of total pharma volume, 2019-24
Figure 102: India generics market geography segmentation: % share, by value, 2024
Figure 103: India generics market value forecast: $ million, 2024-29
Figure 104: India generics market volume forecast: % of total pharma volume, 2024-29
Figure 105: Forces driving competition in the generics market in India, 2024
Figure 106: Drivers of buyer power in the generics market in India, 2024
Figure 107: Drivers of supplier power in the generics market in India, 2024
Figure 108: Factors influencing the likelihood of new entrants in the generics market in India, 2024
Figure 109: Factors influencing the threat of substitutes in the generics market in India, 2024
Figure 110: Drivers of degree of rivalry in the generics market in India, 2024

Generics Global Industry Almanac 2020-2029

Description

Table of Contents

List of Tables

Summary

Key Highlights

Scope

Reasons to Buy

Table of Contents

1 EXECUTIVE SUMMARY

2 Introduction

3 Global Generics

4 Macroeconomic Indicators

5 Generics in Asia-Pacific

6 Generics in Europe

7 Macroeconomic Indicators

8 Generics in France

9 Macroeconomic Indicators

10 Generics in Germany

11 Macroeconomic Indicators

12 Generics in Australia

13 Macroeconomic Indicators

14 Generics in Brazil

15 Macroeconomic Indicators

16 Generics in Canada

17 Macroeconomic Indicators

18 Generics in China

19 Macroeconomic Indicators

20 Generics in India

21 Macroeconomic Indicators

22 Generics in Indonesia

23 Macroeconomic Indicators

24 Generics in Italy

25 Macroeconomic Indicators

26 Generics in Japan

27 Macroeconomic Indicators

28 Generics in Mexico

29 Macroeconomic Indicators

30 Generics in The Netherlands

31 Macroeconomic Indicators

32 Generics in North America

33 Generics in Russia

34 Macroeconomic Indicators

35 Generics in Scandinavia

36 Generics in Singapore

37 Macroeconomic Indicators

38 Generics in South Africa

39 Macroeconomic Indicators

40 Generics in South Korea

41 Macroeconomic Indicators

42 Generics in Spain

43 Macroeconomic Indicators

44 Generics in Turkey

45 Macroeconomic Indicators

46 Generics in The United Kingdom

47 Macroeconomic Indicators

48 Generics in The United States

49 Macroeconomic Indicators

50 Company Profiles

51 Appendix

List of Tables

List of Figures